Transchem Limited , a company listed on the Bombay Stock Exchange (BSE: 500422), has taken steps to modernize its corporate structure and expand its business focus. At an Extraordinary General Meeting (EGM) held on October 16, 2025, shareholders approved two special resolutions that will reshape the company's foundational documents and business objectives.

New Articles of Association

The first resolution involved the adoption of a new set of Articles of Association (AoA) for Transchem Limited. This update aligns the company's AoA with the provisions of the Companies Act, 2013, replacing references to the Companies Act, 1956. The new AoA has been restructured to comply with current legal requirements and incorporates provisions that may allow the company greater flexibility in its operations.

Memorandum of Association Amendments

The second resolution approved amendments to the company's Memorandum of Association (MoA). These changes expand and modernize Transchem Limited's business objectives. The key updates to the MoA include:

1. Broking Services: The company can now engage in broking activities for shares, commodities, and currencies on recognized exchanges.

2. Financial Advisory: Transchem Limited is authorized to provide investment advisory, research, and consultancy services, including portfolio management.

3. Technology Integration: The amendments allow for the development and use of advanced technologies such as artificial intelligence (AI) and machine learning (ML) to enhance business operations.

4. Depository Participant: The company can now act as a depository participant and undertake related activities.

Voting Results

The EGM saw shareholder participation and approval for both resolutions. Here's a breakdown of the voting results:

Implications for Transchem Limited

These changes signify a shift for Transchem Limited, potentially positioning the company to expand into financial services and leverage modern technologies. The shareholder approval suggests support for the company's new direction.

The adoption of the new AoA and the amendments to the MoA reflect Transchem Limited's commitment to corporate governance and its aim to diversify its business activities. These changes could allow the company to explore new revenue streams and adapt to the evolving financial services landscape.

Investors and stakeholders may be watching to see how Transchem Limited implements these new capabilities and what impact they may have on the company's future performance and market position.

Transchem Limited has announced a major strategic shift in its business focus, pivoting from natural products and pharmaceuticals to the financial services sector. The company's Board of Directors approved this significant change during a meeting held on September 23.

Key Developments

• New Business Focus: Transchem is set to enter the financial services sector, moving away from its traditional focus on natural products, herbal, medicinal, and pharmaceutical products.

• Adoption of New AoA and MoA: The Board has approved the adoption of new Articles of Association (AoA) and Memorandum of Association (MoA) to align with the Companies Act, 2013 and the proposed business diversification.

• Shareholder Approval Pending: These changes are subject to shareholder approval at an upcoming Extraordinary General Meeting (EGM).

Expanded Business Objectives

The company's new business objectives, as outlined in the altered Object Clause of the MoA, include:

1. Stockbroking in shares, commodities, and currencies
2. Portfolio management and investment advisory services
3. Fund management
4. Acting as a depository participant

Technological Integration

Transchem plans to leverage advanced technologies, including artificial intelligence and machine learning, to enhance its operations and service delivery in the financial sector.

Management's Perspective

The Board of Directors believes this strategic shift will unlock significant value for shareholders and position the company for sustainable long-term growth in the dynamic financial sector.

Regulatory Compliance

The company has ensured that the new AoA and MoA comply with the provisions of the Companies Act, 2013, and other applicable laws. The adoption of these new documents is aimed at streamlining operations and aligning with current regulatory requirements.

Next Steps

An EGM will be convened to seek shareholder approval for these changes. The notice for the 1st EGM of the financial year, along with the explanatory statement, will be sent to eligible shareholders electronically.

Investors and stakeholders are advised to monitor further announcements from the company regarding the date of the EGM and the detailed proposals for shareholder consideration.

As Transchem Limited embarks on this new journey in the financial services sector, the market will be watching closely to see how this traditional pharmaceutical company transforms itself in the coming months.